MSCV Myc T58A puro Citations (4)
Originally described in: Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants.Hemann MT, Bric A, Teruya-Feldstein J, Herbst A, Nilsson JA, Cordon-Cardo C, Cleveland JL, Tansey WP, Lowe SW Nature. 2005 Aug 11. 436(7052):807-11. PubMed Journal
Articles Citing MSCV Myc T58A puro
Articles |
---|
LACTB is a tumour suppressor that modulates lipid metabolism and cell state. Keckesova Z, Donaher JL, De Cock J, Freinkman E, Lingrell S, Bachovchin DA, Bierie B, Tischler V, Noske A, Okondo MC, Reinhardt F, Thiru P, Golub TR, Vance JE, Weinberg RA. Nature. 2017 Mar 30;543(7647):681-686. doi: 10.1038/nature21408. Epub 2017 Mar 22. PubMed |
The RECQL helicase prevents replication fork collapse during replication stress. Benedict B, van Bueren MA, van Gemert FP, Lieftink C, Guerrero Llobet S, van Vugt MA, Beijersbergen RL, Te Riele H. Life Sci Alliance. 2020 Aug 20;3(10). pii: 3/10/e202000668. doi: 10.26508/lsa.202000668. Print 2020 Oct. PubMed |
Heat shock factor 1 (HSF1) specifically potentiates c-MYC-mediated transcription independently of the canonical heat shock response. Xu M, Lin L, Ram BM, Shriwas O, Chuang KH, Dai S, Su KH, Tang Z, Dai C. Cell Rep. 2023 Jun 27;42(6):112557. doi: 10.1016/j.celrep.2023.112557. Epub 2023 May 23. PubMed |
Recurrent mutations in tumor suppressor FBXW7 bypass Wnt/beta-catenin addiction in cancer. Zhong Z, Virshup DM. Sci Adv. 2024 Apr 5;10(14):eadk1031. doi: 10.1126/sciadv.adk1031. Epub 2024 Apr 3. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.